Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 544

1.

Updating the recommendations for treatment of tardive syndromes: A systematic review of new evidence and practical treatment algorithm.

Bhidayasiri R, Jitkritsadakul O, Friedman JH, Fahn S.

J Neurol Sci. 2018 Feb 5. pii: S0022-510X(18)30068-6. doi: 10.1016/j.jns.2018.02.010. [Epub ahead of print] Review.

PMID:
29454493
2.

The nosology of tardive syndromes.

Frei K, Truong DD, Fahn S, Jankovic J, Hauser RA.

J Neurol Sci. 2018 Feb 6. pii: S0022-510X(18)30066-2. doi: 10.1016/j.jns.2018.02.008. [Epub ahead of print]

PMID:
29433810
3.

Alpha galactosidase A activity in Parkinson's disease.

Alcalay RN, Wolf P, Levy OA, Kang UJ, Waters C, Fahn S, Ford B, Kuo SH, Vanegas N, Shah H, Liong C, Narayan S, Pauciulo MW, Nichols WC, Gan-Or Z, Rouleau GA, Chung WK, Oliva P, Keutzer J, Marder K, Zhang XK.

Neurobiol Dis. 2018 Apr;112:85-90. doi: 10.1016/j.nbd.2018.01.012. Epub 2018 Feb 2.

PMID:
29369793
4.

Two-hundred Years Later: Is Parkinson's Disease a Single Defined Entity?

Rodríguez-Violante M, Cervantes-Arriaga A, Fahn S, Tolosa E.

Rev Invest Clin. 2017 Nov-Dec;69(6):308-313. doi: 10.24875/RIC.17002291.

5.

Adaptation of Stability during Perturbed Walking in Parkinson's Disease.

Martelli D, Luo L, Kang J, Kang UJ, Fahn S, Agrawal SK.

Sci Rep. 2017 Dec 19;7(1):17875. doi: 10.1038/s41598-017-18075-6.

6.

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ.

Mov Disord. 2017 Sep;32(9):1264-1310. doi: 10.1002/mds.27115. Review.

PMID:
28887905
7.

The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future.

Fahn S.

Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S1-S5. doi: 10.1016/j.parkreldis.2017.07.020. Epub 2017 Aug 1.

PMID:
28784297
8.

Personal reflections about Lewis P. (Bud) Rowland (1925-2017).

Fahn S.

Neurology. 2017 May 30;88(22):2078-2079. doi: 10.1212/WNL.0000000000004050. No abstract available.

PMID:
28554897
9.

Inpatient treatment for functional neurologic disorders.

Williams DT, Lafaver K, Carson A, Fahn S.

Handb Clin Neurol. 2016;139:631-641. doi: 10.1016/B978-0-12-801772-2.00051-5. Review.

PMID:
27719878
10.

"Complex" dystonia is not a category in the new 2013 consensus classification.

Albanese A, Bhatia K, DeLong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Mink JW, Teller JK.

Mov Disord. 2016 Nov;31(11):1758-1759. doi: 10.1002/mds.26764. Epub 2016 Sep 10. No abstract available.

PMID:
27612445
11.

SCARB2 variants and glucocerebrosidase activity in Parkinson's disease.

Alcalay RN, Levy OA, Wolf P, Oliva P, Zhang XK, Waters CH, Fahn S, Kang U, Liong C, Ford B, Mazzoni P, Kuo S, Johnson A, Xiong L, Rouleau GA, Chung W, Marder KS, Gan-Or Z.

NPJ Parkinsons Dis. 2016;2. pii: 16004. Epub 2016 Mar 10.

12.

Oliver Sacks, MD, 1933-2015.

Fahn S.

Mov Disord. 2016 Apr;31(4):493-6. doi: 10.1002/mds.26602. No abstract available.

PMID:
27079682
13.

Levodopa therapy for Parkinson disease: A look backward and forward.

LeWitt PA, Fahn S.

Neurology. 2016 Apr 5;86(14 Suppl 1):S3-12. doi: 10.1212/WNL.0000000000002509. Epub 2016 Apr 4. Review.

PMID:
27044648
14.

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.

Huntington Study Group PHAROS Investigators, Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, Siemers E, Tanner C, Mallonee W, Suter G, Dubinsky R, Gray C, Nance M, Bundlie S, Radtke D, Kostyk S, Baic C, Caress J, Walker F, Hunt V, O'Neill C, Chouinard S, Factor S, Greenamyre T, Wood-Siverio C, Corey-Bloom J, Song D, Peavy G, Moskowitz C, Wesson M, Samii A, Bird T, Lipe H, Blindauer K, Marshall F, Zimmerman C, Goldstein J, Rosas D, Novak P, Caviness J, Adler C, Duffy A, Wheelock V, Tempkin T, Richman D, Seeberger L, Albin R, Chou KL, Racette B, Perlmutter JS, Perlman S, Bordelon Y, Martin W, Wieler M, Leavitt B, Raymond L, Decolongon J, Clarke L, Jankovic J, Hunter C, Hauser RA, Sanchez-Ramos J, Furtado S, Suchowersky O, Klimek ML, Guttman M, Sethna R, Feigin A, Cox M, Shannon B, Percy A, Dure L, Harrison M, Johnson W, Higgins D, Molho E, Nickerson C, Evans S, Hobson D, Singer C, Galvez-Jimenez N, Shannon K, Comella C, Ross C, Saint-Hilaire MH, Testa C, Rosenblatt A, Hogarth P, Weiner W, Como P, Kumar R, Cotto C, Stout J, Brocht A, Watts A, Eberly S, Weaver C, Foroud T, Gusella J, MacDonald M, Myers R, Fahn S, Shults C.

JAMA Neurol. 2016 Jan;73(1):102-10. doi: 10.1001/jamaneurol.2015.2736.

PMID:
26569098
15.

Closing the tau loop: the missing tau mutation.

McCarthy A, Lonergan R, Olszewska DA, O'Dowd S, Cummins G, Magennis B, Fallon EM, Pender N, Huey ED, Cosentino S, O'Rourke K, Kelly BD, O'Connell M, Delon I, Farrell M, Spillantini MG, Rowland LP, Fahn S, Craig P, Hutton M, Lynch T.

Brain. 2015 Oct;138(Pt 10):3100-9. doi: 10.1093/brain/awv234. Epub 2015 Aug 21.

16.

Clinicopathological characteristics of freezing of gait in autopsy-confirmed Parkinson's disease.

Virmani T, Moskowitz CB, Vonsattel JP, Fahn S.

Mov Disord. 2015 Dec;30(14):1874-84. doi: 10.1002/mds.26346. Epub 2015 Aug 3.

PMID:
26234730
17.

Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's Disease.

Robakis D, Fahn S.

CNS Drugs. 2015 Jun;29(6):433-41. doi: 10.1007/s40263-015-0249-8. Review.

PMID:
26164425
18.

Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.

Alcalay RN, Levy OA, Waters CC, Fahn S, Ford B, Kuo SH, Mazzoni P, Pauciulo MW, Nichols WC, Gan-Or Z, Rouleau GA, Chung WK, Wolf P, Oliva P, Keutzer J, Marder K, Zhang X.

Brain. 2015 Sep;138(Pt 9):2648-58. doi: 10.1093/brain/awv179. Epub 2015 Jun 27.

19.

Masaya Segawa, MD, PhD, 1936-2014.

Nomura Y, Fahn S.

Mov Disord. 2015 Jun;30(7):883-5. doi: 10.1002/mds.26257. Epub 2015 May 23. No abstract available.

PMID:
26009805
20.

Comparison of clinical features in pathologically confirmed PSP and MSA patients followed at a tertiary center.

Xie T, Kang UJ, Kuo SH, Poulopoulos M, Greene P, Fahn S.

NPJ Parkinsons Dis. 2015 May 21;1:15007. doi: 10.1038/npjparkd.2015.7. eCollection 2015.

Supplemental Content

Support Center